Pelthos Therapeutics Inc. ( PTHS) Q4 2025 Earnings Call March 19, 2026 8:00 AM EDT ...
In an interview with CNBC on Tuesday, Huang emphasised that OpenClaw enables users to perform complex tasks and automation ...
Good day, and thank you for standing by. Welcome to the Alvotech Q4 2025 and Full Year 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being ...
Pelthos Therapeutics Inc (PTHS) reports a 129% increase in prescriptions and strategic acquisitions, bolstering its financial position and setting the stage for future growth.
For many pet owners, the line between a behavioral problem and a normal instinct isn’t always clear, especially when it comes ...
Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results